

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cardiac myofibril assembly (GO:0055003) | 9.04105698 |
| 2 | sarcomere organization (GO:0045214) | 8.76641706 |
| 3 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 8.56993384 |
| 4 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 7.75435831 |
| 5 | myofibril assembly (GO:0030239) | 7.61912708 |
| 6 | tricarboxylic acid cycle (GO:0006099) | 7.26639290 |
| 7 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 6.97044388 |
| 8 | cardiac muscle contraction (GO:0060048) | 6.84387088 |
| 9 | * regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 6.73424612 |
| 10 | cardiac muscle cell development (GO:0055013) | 6.54434546 |
| 11 | regulation of sarcomere organization (GO:0060297) | 6.44866700 |
| 12 | * regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 6.36439869 |
| 13 | ventricular cardiac muscle cell action potential (GO:0086005) | 6.14786375 |
| 14 | cardiac cell development (GO:0055006) | 6.14245029 |
| 15 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 6.13660344 |
| 16 | cardiac muscle hypertrophy (GO:0003300) | 6.01978940 |
| 17 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 5.94438062 |
| 18 | * regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 5.88466916 |
| 19 | cardiac muscle tissue morphogenesis (GO:0055008) | 5.74555450 |
| 20 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 5.70816775 |
| 21 | heart trabecula formation (GO:0060347) | 5.69589912 |
| 22 | muscle filament sliding (GO:0030049) | 5.68801102 |
| 23 | actin-myosin filament sliding (GO:0033275) | 5.68801102 |
| 24 | striated muscle hypertrophy (GO:0014897) | 5.67989944 |
| 25 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 5.54617096 |
| 26 | adult heart development (GO:0007512) | 5.51918482 |
| 27 | actomyosin structure organization (GO:0031032) | 5.49656607 |
| 28 | regulation of cell communication by electrical coupling (GO:0010649) | 5.49452713 |
| 29 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 5.42418858 |
| 30 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 5.39793820 |
| 31 | cardiac chamber formation (GO:0003207) | 5.37423951 |
| 32 | carnitine shuttle (GO:0006853) | 5.33215890 |
| 33 | cell communication involved in cardiac conduction (GO:0086065) | 5.29596552 |
| 34 | * regulation of actin filament-based movement (GO:1903115) | 5.15435420 |
| 35 | muscle tissue morphogenesis (GO:0060415) | 5.09081370 |
| 36 | plasma membrane repair (GO:0001778) | 5.07285517 |
| 37 | heart process (GO:0003015) | 5.07057432 |
| 38 | heart contraction (GO:0060047) | 5.07057432 |
| 39 | muscle hypertrophy (GO:0014896) | 5.04241263 |
| 40 | regulation of membrane repolarization (GO:0060306) | 5.00520610 |
| 41 | regulation of coenzyme metabolic process (GO:0051196) | 4.95478410 |
| 42 | regulation of cofactor metabolic process (GO:0051193) | 4.95478410 |
| 43 | cardiac ventricle formation (GO:0003211) | 4.90951809 |
| 44 | striated muscle contraction (GO:0006941) | 4.88150146 |
| 45 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.85224838 |
| 46 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.84451241 |
| 47 | * regulation of striated muscle contraction (GO:0006942) | 4.81846229 |
| 48 | fatty acid transmembrane transport (GO:1902001) | 4.77655905 |
| 49 | regulation of skeletal muscle contraction (GO:0014819) | 4.77001516 |
| 50 | actin-mediated cell contraction (GO:0070252) | 4.74410873 |
| 51 | cell communication by electrical coupling (GO:0010644) | 4.66790563 |
| 52 | * regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.62175953 |
| 53 | * regulation of relaxation of muscle (GO:1901077) | 4.58209448 |
| 54 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.57065942 |
| 55 | response to inactivity (GO:0014854) | 4.55599780 |
| 56 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.53863471 |
| 57 | ATP synthesis coupled proton transport (GO:0015986) | 4.53863471 |
| 58 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.49385771 |
| 59 | respiratory electron transport chain (GO:0022904) | 4.46074995 |
| 60 | muscle contraction (GO:0006936) | 4.38935563 |
| 61 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 4.36262495 |
| 62 | muscle hypertrophy in response to stress (GO:0003299) | 4.36262495 |
| 63 | cardiac muscle adaptation (GO:0014887) | 4.36262495 |
| 64 | skeletal muscle contraction (GO:0003009) | 4.33931713 |
| 65 | oxidative phosphorylation (GO:0006119) | 4.32861558 |
| 66 | electron transport chain (GO:0022900) | 4.32503478 |
| 67 | ventricular cardiac muscle cell development (GO:0055015) | 4.30132748 |
| 68 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 4.29876124 |
| 69 | cardiac muscle cell action potential (GO:0086001) | 4.27611265 |
| 70 | * regulation of the force of heart contraction (GO:0002026) | 4.24344477 |
| 71 | * regulation of cardiac muscle contraction (GO:0055117) | 4.23572420 |
| 72 | negative regulation of potassium ion transport (GO:0043267) | 4.19692464 |
| 73 | 2-oxoglutarate metabolic process (GO:0006103) | 4.12574278 |
| 74 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 4.12288007 |
| 75 | regulation of sulfur metabolic process (GO:0042762) | 4.05289191 |
| 76 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 4.03608987 |
| 77 | NADH metabolic process (GO:0006734) | 4.02404566 |
| 78 | * muscle system process (GO:0003012) | 3.97723587 |
| 79 | response to caffeine (GO:0031000) | 3.97682913 |
| 80 | * regulation of heart rate (GO:0002027) | 3.97637990 |
| 81 | cellular response to epinephrine stimulus (GO:0071872) | 3.97027755 |
| 82 | response to epinephrine (GO:0071871) | 3.96561457 |
| 83 | carnitine transmembrane transport (GO:1902603) | 3.96022532 |
| 84 | regulation of cardioblast differentiation (GO:0051890) | 3.94348709 |
| 85 | striated muscle adaptation (GO:0014888) | 3.92157608 |
| 86 | regulation of heart rate by cardiac conduction (GO:0086091) | 3.77621675 |
| 87 | * regulation of heart contraction (GO:0008016) | 3.73241193 |
| 88 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.72766865 |
| 89 | creatine metabolic process (GO:0006600) | 3.70717252 |
| 90 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 3.70315469 |
| 91 | detection of calcium ion (GO:0005513) | 3.69707564 |
| 92 | atrial septum morphogenesis (GO:0060413) | 3.66939348 |
| 93 | * regulation of muscle contraction (GO:0006937) | 3.64458692 |
| 94 | negative regulation of protein localization to cell surface (GO:2000009) | 3.64157624 |
| 95 | regulation of sequestering of triglyceride (GO:0010889) | 3.62721738 |
| 96 | fatty acid beta-oxidation (GO:0006635) | 3.61543210 |
| 97 | amino-acid betaine transport (GO:0015838) | 3.60613966 |
| 98 | carnitine transport (GO:0015879) | 3.60613966 |
| 99 | trabecula formation (GO:0060343) | 3.58190169 |
| 100 | * relaxation of cardiac muscle (GO:0055119) | 3.57885336 |
| 101 | muscle fiber development (GO:0048747) | 3.57768153 |
| 102 | actin filament-based movement (GO:0030048) | 3.55244670 |
| 103 | aspartate family amino acid catabolic process (GO:0009068) | 3.53492899 |
| 104 | positive regulation of heart rate (GO:0010460) | 3.53392895 |
| 105 | positive regulation of cation channel activity (GO:2001259) | 3.52056179 |
| 106 | striated muscle cell development (GO:0055002) | 3.49684712 |
| 107 | * regulation of cardiac muscle cell contraction (GO:0086004) | 3.49594484 |
| 108 | muscle cell development (GO:0055001) | 3.48866208 |
| 109 | * regulation of muscle system process (GO:0090257) | 3.47363692 |
| 110 | positive regulation of heart contraction (GO:0045823) | 3.46819962 |
| 111 | * regulation of calcium ion transmembrane transport (GO:1903169) | 3.42425532 |
| 112 | * regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.42425532 |
| 113 | potassium ion export (GO:0071435) | 3.42221934 |
| 114 | regulation of fatty acid oxidation (GO:0046320) | 3.41927896 |
| 115 | succinate metabolic process (GO:0006105) | 3.38874883 |
| 116 | negative regulation of myotube differentiation (GO:0010832) | 3.37727605 |
| 117 | positive regulation of ATPase activity (GO:0032781) | 3.34091678 |
| 118 | positive regulation of ATP catabolic process (GO:1903291) | 3.34091678 |
| 119 | lysine metabolic process (GO:0006553) | 3.32563008 |
| 120 | lysine catabolic process (GO:0006554) | 3.32563008 |
| 121 | * cardiac conduction (GO:0061337) | 3.31416911 |
| 122 | * regulation of ATP catabolic process (GO:1903289) | 3.29557728 |
| 123 | * regulation of ATPase activity (GO:0043462) | 3.29557728 |
| 124 | atrioventricular valve morphogenesis (GO:0003181) | 3.27153348 |
| 125 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.25008378 |
| 126 | positive regulation of sodium ion transport (GO:0010765) | 3.24110228 |
| 127 | muscle adaptation (GO:0043500) | 3.13974359 |
| 128 | regulation of cardioblast proliferation (GO:0003264) | 3.08272303 |
| 129 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 3.08272303 |
| 130 | response to muscle activity (GO:0014850) | 3.08271654 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 7.44317972 |
| 2 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 5.46307009 |
| 3 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 4.88850453 |
| 4 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 4.29579514 |
| 5 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 4.28887184 |
| 6 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 4.28887184 |
| 7 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 4.14404284 |
| 8 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 3.38855336 |
| 9 | ZNF263_19887448_ChIP-Seq_K562_Human | 3.18530583 |
| 10 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.98222432 |
| 11 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.97555792 |
| 12 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 2.66890118 |
| 13 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.55359944 |
| 14 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.17619243 |
| 15 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 2.15097010 |
| 16 | VDR_22108803_ChIP-Seq_LS180_Human | 2.14695472 |
| 17 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 2.13839871 |
| 18 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.13697965 |
| 19 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.08677161 |
| 20 | GATA1_22025678_ChIP-Seq_K562_Human | 2.04484234 |
| 21 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.98499789 |
| 22 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.97410000 |
| 23 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.92001423 |
| 24 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.85965514 |
| 25 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.74716277 |
| 26 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.50704637 |
| 27 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.47464481 |
| 28 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.44271407 |
| 29 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.42391250 |
| 30 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.42324416 |
| 31 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.40505147 |
| 32 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.38628732 |
| 33 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.38611752 |
| 34 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.35999045 |
| 35 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.32587284 |
| 36 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.32074884 |
| 37 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.32027212 |
| 38 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.30787282 |
| 39 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.29687513 |
| 40 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.29514131 |
| 41 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.29414220 |
| 42 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.28086211 |
| 43 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.27363631 |
| 44 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.23562804 |
| 45 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.23015043 |
| 46 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.21429128 |
| 47 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.19112831 |
| 48 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.16374699 |
| 49 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.16044299 |
| 50 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.14906134 |
| 51 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.12592347 |
| 52 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.12592347 |
| 53 | GATA1_19941826_ChIP-Seq_K562_Human | 1.11581672 |
| 54 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.11306104 |
| 55 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.07285905 |
| 56 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.06454119 |
| 57 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.05835713 |
| 58 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.03225876 |
| 59 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.00827056 |
| 60 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.00796654 |
| 61 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.00367661 |
| 62 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.00153822 |
| 63 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.00014840 |
| 64 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.99407893 |
| 65 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.98479277 |
| 66 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.98360746 |
| 67 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.98271475 |
| 68 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.98013568 |
| 69 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.97738870 |
| 70 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.97354975 |
| 71 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.97088711 |
| 72 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.97070564 |
| 73 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.96807439 |
| 74 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.96802288 |
| 75 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.96553262 |
| 76 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.96401093 |
| 77 | CJUN_26792858_Chip-Seq_BT549_Human | 0.95905224 |
| 78 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.95814592 |
| 79 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.95092630 |
| 80 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.94792064 |
| 81 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.94430045 |
| 82 | TCF4_23295773_ChIP-Seq_U87_Human | 0.93915822 |
| 83 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.93624614 |
| 84 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.93596890 |
| 85 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.92836451 |
| 86 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.92805343 |
| 87 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.91423799 |
| 88 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.91251495 |
| 89 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.91210244 |
| 90 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.90838420 |
| 91 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.90740705 |
| 92 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.90473103 |
| 93 | TBL1_22424771_ChIP-Seq_293T_Human | 0.89366502 |
| 94 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.87633778 |
| 95 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.87520812 |
| 96 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.86643549 |
| 97 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.85856900 |
| 98 | GATA2_19941826_ChIP-Seq_K562_Human | 0.85528890 |
| 99 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.85434250 |
| 100 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.85293325 |
| 101 | ATF3_27146783_Chip-Seq_COLON_Human | 0.85277238 |
| 102 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.85121588 |
| 103 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.85118390 |
| 104 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.84727214 |
| 105 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.84664275 |
| 106 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.84561710 |
| 107 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.83992791 |
| 108 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.83953340 |
| 109 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.83076113 |
| 110 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.82925541 |
| 111 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.81048444 |
| 112 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.80739950 |
| 113 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.80580628 |
| 114 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.79943112 |
| 115 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79355514 |
| 116 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.78726216 |
| 117 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.78500219 |
| 118 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.78006519 |
| 119 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.77914152 |
| 120 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.76488828 |
| 121 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.76301279 |
| 122 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.76032702 |
| 123 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.75597833 |
| 124 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.75516255 |
| 125 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.75394386 |
| 126 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.75277864 |
| 127 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.74358151 |
| 128 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.73790604 |
| 129 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.72783316 |
| 130 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.72401696 |
| 131 | SPI1_23127762_ChIP-Seq_K562_Human | 0.71907643 |
| 132 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.70707487 |
| 133 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.70065478 |
| 134 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.69791369 |
| 135 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.69436128 |
| 136 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.68370590 |
| 137 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.68151726 |
| 138 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.65830460 |
| 139 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.65821870 |
| 140 | TP53_16413492_ChIP-PET_HCT116_Human | 0.65440966 |
| 141 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.65382659 |
| 142 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.65316122 |
| 143 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.64915042 |
| 144 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.64787366 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 6.67144350 |
| 2 | * MP0004084_abnormal_cardiac_muscle | 5.59460164 |
| 3 | MP0003646_muscle_fatigue | 5.38102026 |
| 4 | * MP0004215_abnormal_myocardial_fiber | 5.04430562 |
| 5 | MP0000751_myopathy | 4.92856098 |
| 6 | MP0005330_cardiomyopathy | 4.27817172 |
| 7 | * MP0004036_abnormal_muscle_relaxation | 3.88905409 |
| 8 | MP0000749_muscle_degeneration | 3.45634609 |
| 9 | MP0002972_abnormal_cardiac_muscle | 3.45268741 |
| 10 | MP0003137_abnormal_impulse_conducting | 3.24656634 |
| 11 | MP0004087_abnormal_muscle_fiber | 3.07105161 |
| 12 | MP0004484_altered_response_of | 2.90300660 |
| 13 | MP0010630_abnormal_cardiac_muscle | 2.85564892 |
| 14 | * MP0008775_abnormal_heart_ventricle | 2.84040194 |
| 15 | MP0004130_abnormal_muscle_cell | 2.79189725 |
| 16 | * MP0005385_cardiovascular_system_phenoty | 2.78379636 |
| 17 | * MP0001544_abnormal_cardiovascular_syste | 2.78379636 |
| 18 | MP0005620_abnormal_muscle_contractility | 2.74461061 |
| 19 | MP0000750_abnormal_muscle_regeneration | 2.65472450 |
| 20 | MP0006138_congestive_heart_failure | 2.64373650 |
| 21 | MP0003828_pulmonary_edema | 2.64065002 |
| 22 | MP0004085_abnormal_heartbeat | 2.44774141 |
| 23 | MP0002106_abnormal_muscle_physiology | 2.38511349 |
| 24 | MP0004510_myositis | 2.20759984 |
| 25 | MP0003221_abnormal_cardiomyocyte_apopto | 2.11736209 |
| 26 | MP0002269_muscular_atrophy | 2.09838119 |
| 27 | MP0005369_muscle_phenotype | 1.90200254 |
| 28 | MP0006036_abnormal_mitochondrial_physio | 1.88139583 |
| 29 | MP0002127_abnormal_cardiovascular_syste | 1.86739661 |
| 30 | MP0004145_abnormal_muscle_electrophysio | 1.79386061 |
| 31 | MP0000759_abnormal_skeletal_muscle | 1.71773104 |
| 32 | MP0000747_muscle_weakness | 1.68538549 |
| 33 | MP0003950_abnormal_plasma_membrane | 1.64327509 |
| 34 | MP0004233_abnormal_muscle_weight | 1.61495786 |
| 35 | MP0003567_abnormal_fetal_cardiomyocyte | 1.57708405 |
| 36 | MP0002332_abnormal_exercise_endurance | 1.39605205 |
| 37 | MP0005666_abnormal_adipose_tissue | 1.38500019 |
| 38 | MP0010368_abnormal_lymphatic_system | 1.36245537 |
| 39 | MP0005165_increased_susceptibility_to | 1.35847458 |
| 40 | MP0000343_altered_response_to | 1.32928937 |
| 41 | MP0000266_abnormal_heart_morphology | 1.26433589 |
| 42 | MP0003279_aneurysm | 1.20381975 |
| 43 | MP0001661_extended_life_span | 1.18089876 |
| 44 | MP0006035_abnormal_mitochondrial_morpho | 1.14358630 |
| 45 | MP0005670_abnormal_white_adipose | 1.11322840 |
| 46 | MP0002234_abnormal_pharynx_morphology | 1.09222615 |
| 47 | MP0005375_adipose_tissue_phenotype | 0.89793791 |
| 48 | MP0000230_abnormal_systemic_arterial | 0.89767768 |
| 49 | MP0004185_abnormal_adipocyte_glucose | 0.88764868 |
| 50 | MP0002128_abnormal_blood_circulation | 0.87680820 |
| 51 | MP0005623_abnormal_meninges_morphology | 0.86204331 |
| 52 | MP0003566_abnormal_cell_adhesion | 0.85341998 |
| 53 | MP0005266_abnormal_metabolism | 0.78961191 |
| 54 | MP0001879_abnormal_lymphatic_vessel | 0.78073391 |
| 55 | MP0003045_fibrosis | 0.73875808 |
| 56 | MP0004043_abnormal_pH_regulation | 0.73695604 |
| 57 | MP0002108_abnormal_muscle_morphology | 0.70408913 |
| 58 | MP0004272_abnormal_basement_membrane | 0.67619238 |
| 59 | MP0005503_abnormal_tendon_morphology | 0.67553406 |
| 60 | MP0000767_abnormal_smooth_muscle | 0.64414301 |
| 61 | MP0002909_abnormal_adrenal_gland | 0.64051104 |
| 62 | MP0004147_increased_porphyrin_level | 0.58526621 |
| 63 | MP0005451_abnormal_body_composition | 0.55934867 |
| 64 | MP0003705_abnormal_hypodermis_morpholog | 0.55229681 |
| 65 | MP0005187_abnormal_penis_morphology | 0.55118274 |
| 66 | MP0000003_abnormal_adipose_tissue | 0.54629327 |
| 67 | MP0003806_abnormal_nucleotide_metabolis | 0.53981171 |
| 68 | MP0009384_cardiac_valve_regurgitation | 0.52425397 |
| 69 | MP0002925_abnormal_cardiovascular_devel | 0.51301691 |
| 70 | MP0005319_abnormal_enzyme/_coenzyme | 0.51294340 |
| 71 | MP0008438_abnormal_cutaneous_collagen | 0.49754414 |
| 72 | MP0002078_abnormal_glucose_homeostasis | 0.49477812 |
| 73 | MP0000013_abnormal_adipose_tissue | 0.48814993 |
| 74 | MP0003984_embryonic_growth_retardation | 0.48005270 |
| 75 | MP0002971_abnormal_brown_adipose | 0.47240612 |
| 76 | MP0002088_abnormal_embryonic_growth/wei | 0.46915498 |
| 77 | MP0003941_abnormal_skin_development | 0.45025798 |
| 78 | MP0008004_abnormal_stomach_pH | 0.43479364 |
| 79 | MP0001614_abnormal_blood_vessel | 0.41715841 |
| 80 | MP0001784_abnormal_fluid_regulation | 0.41293285 |
| 81 | MP0005535_abnormal_body_temperature | 0.39467194 |
| 82 | MP0005275_abnormal_skin_tensile | 0.38365024 |
| 83 | MP0000733_abnormal_muscle_development | 0.38175253 |
| 84 | MP0000462_abnormal_digestive_system | 0.38001238 |
| 85 | MP0004924_abnormal_behavior | 0.37848680 |
| 86 | MP0005386_behavior/neurological_phenoty | 0.37848680 |
| 87 | MP0008961_abnormal_basal_metabolism | 0.37624568 |
| 88 | MP0002638_abnormal_pupillary_reflex | 0.35354739 |
| 89 | MP0005085_abnormal_gallbladder_physiolo | 0.34080322 |
| 90 | MP0001984_abnormal_olfaction | 0.32722946 |
| 91 | MP0005595_abnormal_vascular_smooth | 0.32162146 |
| 92 | MP0008569_lethality_at_weaning | 0.31935817 |
| 93 | MP0003136_yellow_coat_color | 0.31606019 |
| 94 | MP0001299_abnormal_eye_distance/ | 0.31585599 |
| 95 | MP0005167_abnormal_blood-brain_barrier | 0.30176128 |
| 96 | MP0005248_abnormal_Harderian_gland | 0.29391330 |
| 97 | MP0003948_abnormal_gas_homeostasis | 0.28330797 |
| 98 | MP0005171_absent_coat_pigmentation | 0.28310641 |
| 99 | MP0001727_abnormal_embryo_implantation | 0.28196747 |
| 100 | MP0003195_calcinosis | 0.27803356 |
| 101 | MP0002118_abnormal_lipid_homeostasis | 0.27648691 |
| 102 | MP0002295_abnormal_pulmonary_circulatio | 0.26558101 |
| 103 | MP0005332_abnormal_amino_acid | 0.26467841 |
| 104 | MP0005388_respiratory_system_phenotype | 0.26342148 |
| 105 | MP0002133_abnormal_respiratory_system | 0.26342148 |
| 106 | MP0003878_abnormal_ear_physiology | 0.26271362 |
| 107 | MP0005377_hearing/vestibular/ear_phenot | 0.26271362 |
| 108 | MP0002822_catalepsy | 0.26124114 |
| 109 | MP0000249_abnormal_blood_vessel | 0.25710812 |
| 110 | MP0009780_abnormal_chondrocyte_physiolo | 0.25170893 |
| 111 | MP0001672_abnormal_embryogenesis/_devel | 0.25081866 |
| 112 | MP0005380_embryogenesis_phenotype | 0.25081866 |
| 113 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.23987867 |
| 114 | MP0005409_darkened_coat_color | 0.22771467 |
| 115 | MP0008874_decreased_physiological_sensi | 0.22187288 |
| 116 | MP0002102_abnormal_ear_morphology | 0.18475149 |
| 117 | MP0009250_abnormal_appendicular_skeleto | 0.18451131 |
| 118 | MP0001958_emphysema | 0.17894693 |
| 119 | MP0000579_abnormal_nail_morphology | 0.17389522 |
| 120 | MP0000762_abnormal_tongue_morphology | 0.17300119 |
| 121 | MP0009115_abnormal_fat_cell | 0.16648067 |
| 122 | MP0000372_irregular_coat_pigmentation | 0.15162712 |
| 123 | MP0005334_abnormal_fat_pad | 0.14891368 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 8.52731934 |
| 2 | Ventricular tachycardia (HP:0004756) | 7.45025116 |
| 3 | * Atrial fibrillation (HP:0005110) | 6.36841072 |
| 4 | * Primary atrial arrhythmia (HP:0001692) | 5.94487260 |
| 5 | Muscle fiber inclusion bodies (HP:0100299) | 5.82503991 |
| 6 | Calf muscle hypertrophy (HP:0008981) | 5.80225720 |
| 7 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 5.76933117 |
| 8 | * Supraventricular tachycardia (HP:0004755) | 5.74104788 |
| 9 | Syncope (HP:0001279) | 5.68014880 |
| 10 | * Supraventricular arrhythmia (HP:0005115) | 5.62415365 |
| 11 | Nemaline bodies (HP:0003798) | 5.61899512 |
| 12 | Type 1 muscle fiber predominance (HP:0003803) | 5.59926264 |
| 13 | Right ventricular cardiomyopathy (HP:0011663) | 5.44992625 |
| 14 | * Lipoatrophy (HP:0100578) | 5.29438566 |
| 15 | Exercise-induced muscle cramps (HP:0003710) | 5.20871109 |
| 16 | Muscle hypertrophy of the lower extremities (HP:0008968) | 5.17633432 |
| 17 | Exercise-induced myalgia (HP:0003738) | 4.97432608 |
| 18 | Abnormality of the calf musculature (HP:0001430) | 4.96376984 |
| 19 | Muscle fiber splitting (HP:0003555) | 4.93901961 |
| 20 | Bundle branch block (HP:0011710) | 4.91084208 |
| 21 | Palpitations (HP:0001962) | 4.86238488 |
| 22 | Myoglobinuria (HP:0002913) | 4.83052631 |
| 23 | Subaortic stenosis (HP:0001682) | 4.78318060 |
| 24 | Abnormality of the left ventricular outflow tract (HP:0011103) | 4.78318060 |
| 25 | Prolonged QT interval (HP:0001657) | 4.70260992 |
| 26 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 4.51716431 |
| 27 | * Dilated cardiomyopathy (HP:0001644) | 4.40564666 |
| 28 | Hyporeflexia of lower limbs (HP:0002600) | 4.36551830 |
| 29 | Ventricular fibrillation (HP:0001663) | 4.12671174 |
| 30 | Heart block (HP:0012722) | 4.12156418 |
| 31 | Atrioventricular block (HP:0001678) | 4.02060090 |
| 32 | * Ventricular arrhythmia (HP:0004308) | 4.01820964 |
| 33 | EMG: neuropathic changes (HP:0003445) | 3.93682605 |
| 34 | Asymmetric septal hypertrophy (HP:0001670) | 3.92532983 |
| 35 | Abnormal atrioventricular conduction (HP:0005150) | 3.87768757 |
| 36 | Rimmed vacuoles (HP:0003805) | 3.76791273 |
| 37 | Rhabdomyolysis (HP:0003201) | 3.63515538 |
| 38 | EMG: myopathic abnormalities (HP:0003458) | 3.56572036 |
| 39 | Hepatic necrosis (HP:0002605) | 3.44710354 |
| 40 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.41237492 |
| 41 | Abnormal EKG (HP:0003115) | 3.40070176 |
| 42 | Acute necrotizing encephalopathy (HP:0006965) | 3.34328153 |
| 43 | Increased connective tissue (HP:0009025) | 3.30793586 |
| 44 | Hypoglycemic coma (HP:0001325) | 3.28540320 |
| 45 | Ketoacidosis (HP:0001993) | 3.08641962 |
| 46 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.96527706 |
| 47 | Myotonia (HP:0002486) | 2.90825298 |
| 48 | Hepatocellular necrosis (HP:0001404) | 2.90226779 |
| 49 | Acute encephalopathy (HP:0006846) | 2.88739100 |
| 50 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.86143635 |
| 51 | Difficulty running (HP:0009046) | 2.83866324 |
| 52 | Progressive macrocephaly (HP:0004481) | 2.81559680 |
| 53 | Dicarboxylic aciduria (HP:0003215) | 2.80705801 |
| 54 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.80705801 |
| 55 | Generalized muscle weakness (HP:0003324) | 2.76240077 |
| 56 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.74506531 |
| 57 | * Left ventricular hypertrophy (HP:0001712) | 2.74476382 |
| 58 | Cerebral edema (HP:0002181) | 2.72103861 |
| 59 | Mitochondrial inheritance (HP:0001427) | 2.68779297 |
| 60 | Conjunctival hamartoma (HP:0100780) | 2.64290647 |
| 61 | * Palmoplantar keratoderma (HP:0000982) | 2.61914902 |
| 62 | Increased CSF lactate (HP:0002490) | 2.60630786 |
| 63 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.60183216 |
| 64 | Abnormality of alanine metabolism (HP:0010916) | 2.60183216 |
| 65 | Hyperalaninemia (HP:0003348) | 2.60183216 |
| 66 | Ragged-red muscle fibers (HP:0003200) | 2.58429919 |
| 67 | Increased muscle lipid content (HP:0009058) | 2.55625008 |
| 68 | Myopathic facies (HP:0002058) | 2.47264056 |
| 69 | Sudden cardiac death (HP:0001645) | 2.44864998 |
| 70 | Hip contracture (HP:0003273) | 2.44313429 |
| 71 | Difficulty climbing stairs (HP:0003551) | 2.39791906 |
| 72 | Pheochromocytoma (HP:0002666) | 2.39367685 |
| 73 | Distal arthrogryposis (HP:0005684) | 2.39359120 |
| 74 | Hypoplastic left heart (HP:0004383) | 2.38727944 |
| 75 | Lactic acidosis (HP:0003128) | 2.38631669 |
| 76 | Foot dorsiflexor weakness (HP:0009027) | 2.35477839 |
| 77 | Distal lower limb muscle weakness (HP:0009053) | 2.34879917 |
| 78 | Respiratory failure (HP:0002878) | 2.30342023 |
| 79 | Frequent falls (HP:0002359) | 2.28937521 |
| 80 | Scapular winging (HP:0003691) | 2.25907651 |
| 81 | Muscular dystrophy (HP:0003560) | 2.25188016 |
| 82 | Increased intramyocellular lipid droplets (HP:0012240) | 2.25185321 |
| 83 | Neoplasm of the adrenal gland (HP:0100631) | 2.23779177 |
| 84 | Exercise intolerance (HP:0003546) | 2.22954551 |
| 85 | Ketosis (HP:0001946) | 2.21637129 |
| 86 | Distal lower limb amyotrophy (HP:0008944) | 2.20121774 |
| 87 | Round ear (HP:0100830) | 2.19327112 |
| 88 | Bradycardia (HP:0001662) | 2.17787307 |
| 89 | Generalized aminoaciduria (HP:0002909) | 2.15431100 |
| 90 | Neuroendocrine neoplasm (HP:0100634) | 2.15229321 |
| 91 | Steppage gait (HP:0003376) | 2.13687803 |
| 92 | Increased serum pyruvate (HP:0003542) | 2.12437341 |
| 93 | Abnormality of glycolysis (HP:0004366) | 2.12437341 |
| 94 | Limb-girdle muscle atrophy (HP:0003797) | 2.10311327 |
| 95 | Hamartoma of the eye (HP:0010568) | 2.08854353 |
| 96 | Testicular atrophy (HP:0000029) | 2.08758445 |
| 97 | Toxemia of pregnancy (HP:0100603) | 2.07924487 |
| 98 | Areflexia of lower limbs (HP:0002522) | 2.07720275 |
| 99 | Hypoplastic heart (HP:0001961) | 2.07394357 |
| 100 | Progressive muscle weakness (HP:0003323) | 2.06173595 |
| 101 | Increased variability in muscle fiber diameter (HP:0003557) | 2.05669584 |
| 102 | Neoplasm of head and neck (HP:0012288) | 2.03769843 |
| 103 | Esophageal neoplasm (HP:0100751) | 2.03769843 |
| 104 | Muscle stiffness (HP:0003552) | 2.02354329 |
| 105 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.01630049 |
| 106 | Dysmetric saccades (HP:0000641) | 2.01602019 |
| 107 | Gowers sign (HP:0003391) | 2.00958770 |
| 108 | Hypoplastic ischia (HP:0003175) | 2.00086840 |
| 109 | Large for gestational age (HP:0001520) | 1.97031002 |
| 110 | Central scotoma (HP:0000603) | 1.95963468 |
| 111 | * Congestive heart failure (HP:0001635) | 1.94804846 |
| 112 | Nausea (HP:0002018) | 1.92028558 |
| 113 | Hyperammonemia (HP:0001987) | 1.90110310 |
| 114 | Congenital malformation of the right heart (HP:0011723) | 1.89709088 |
| 115 | Double outlet right ventricle (HP:0001719) | 1.89709088 |
| 116 | Lymphangioma (HP:0100764) | 1.89090002 |
| 117 | Lipid accumulation in hepatocytes (HP:0006561) | 1.88677398 |
| 118 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.88569995 |
| 119 | Broad metatarsal (HP:0001783) | 1.87653127 |
| 120 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.86406611 |
| 121 | Abnormality of the foot musculature (HP:0001436) | 1.85737743 |
| 122 | Ulnar deviation of the wrist (HP:0003049) | 1.85324913 |
| 123 | Abnormality of the tricuspid valve (HP:0001702) | 1.84256767 |
| 124 | Neck muscle weakness (HP:0000467) | 1.80620016 |
| 125 | Athetosis (HP:0002305) | 1.80127081 |
| 126 | Tinnitus (HP:0000360) | 1.78041751 |
| 127 | Multiple enchondromatosis (HP:0005701) | 1.76268166 |
| 128 | Bulbar palsy (HP:0001283) | 1.75480562 |
| 129 | Hyperglycemia (HP:0003074) | 1.75121259 |
| 130 | Abnormality of the ischium (HP:0003174) | 1.74696570 |
| 131 | Limited hip movement (HP:0008800) | 1.73049444 |
| 132 | Proximal amyotrophy (HP:0007126) | 1.71970317 |
| 133 | Waddling gait (HP:0002515) | 1.66576341 |
| 134 | Diaphragmatic weakness (HP:0009113) | 1.63150674 |
| 135 | Lower limb amyotrophy (HP:0007210) | 1.61208613 |
| 136 | Absent phalangeal crease (HP:0006109) | 1.53531828 |
| 137 | Abnormality of the endocardium (HP:0004306) | 1.53278777 |
| 138 | Childhood onset (HP:0011463) | 1.50553579 |
| 139 | Calcaneovalgus deformity (HP:0001848) | 1.47679403 |
| 140 | Weak cry (HP:0001612) | 1.46079621 |
| 141 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.45688670 |
| 142 | Periauricular skin pits (HP:0100277) | 1.45360262 |
| 143 | Preauricular pit (HP:0004467) | 1.45360262 |
| 144 | Skin pits (HP:0100276) | 1.43344106 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 5.46231097 |
| 2 | LMTK2 | 4.31716038 |
| 3 | PDK4 | 4.08082707 |
| 4 | PDK3 | 4.08082707 |
| 5 | MYLK | 3.97185688 |
| 6 | PHKG2 | 3.69413927 |
| 7 | PHKG1 | 3.69413927 |
| 8 | PKN2 | 3.62704375 |
| 9 | OBSCN | 3.17713345 |
| 10 | DMPK | 3.03442097 |
| 11 | STK24 | 2.78719405 |
| 12 | TRIB3 | 2.60022663 |
| 13 | PDK2 | 2.51624774 |
| 14 | TIE1 | 2.50504244 |
| 15 | NEK1 | 2.41742653 |
| 16 | BCKDK | 2.37056747 |
| 17 | GRK7 | 2.19719655 |
| 18 | PIK3CA | 2.14268576 |
| 19 | PINK1 | 1.91620471 |
| 20 | MUSK | 1.81403523 |
| 21 | PAK3 | 1.52461060 |
| 22 | CAMK2D | 1.46000211 |
| 23 | ILK | 1.38515340 |
| 24 | PRKD1 | 1.38423249 |
| 25 | PIK3CG | 1.32590885 |
| 26 | WNK4 | 1.30786642 |
| 27 | INSRR | 1.19296042 |
| 28 | MARK1 | 1.17902458 |
| 29 | FLT3 | 1.14676013 |
| 30 | STK4 | 1.11069462 |
| 31 | CDC42BPA | 1.09793964 |
| 32 | ZAK | 1.00473015 |
| 33 | TRPM7 | 0.97548041 |
| 34 | MAP3K7 | 0.97436808 |
| 35 | ROCK1 | 0.97257230 |
| 36 | STK38L | 0.92695364 |
| 37 | MAPK12 | 0.89346024 |
| 38 | PRKAA2 | 0.85238411 |
| 39 | PRKAA1 | 0.84905060 |
| 40 | KDR | 0.80639861 |
| 41 | STK39 | 0.79250879 |
| 42 | DAPK3 | 0.78922369 |
| 43 | MAP3K6 | 0.78846129 |
| 44 | WNK1 | 0.77800726 |
| 45 | PDGFRA | 0.76634001 |
| 46 | MAP3K5 | 0.76389910 |
| 47 | RIPK1 | 0.71842776 |
| 48 | PKN1 | 0.69198166 |
| 49 | STK38 | 0.68956826 |
| 50 | TGFBR2 | 0.64717113 |
| 51 | MAPKAPK3 | 0.63642994 |
| 52 | NEK9 | 0.59100889 |
| 53 | NME2 | 0.58038821 |
| 54 | ROCK2 | 0.57390073 |
| 55 | MAPK4 | 0.54594968 |
| 56 | RPS6KL1 | 0.53373431 |
| 57 | RPS6KC1 | 0.53373431 |
| 58 | PTK2B | 0.51998279 |
| 59 | PRKCE | 0.51933615 |
| 60 | * CAMK2A | 0.51703684 |
| 61 | CAMK2B | 0.50224729 |
| 62 | PRKACB | 0.48860216 |
| 63 | MAP2K3 | 0.47773129 |
| 64 | EEF2K | 0.46384492 |
| 65 | RPS6KA6 | 0.44742593 |
| 66 | PDPK1 | 0.43795812 |
| 67 | MAP3K3 | 0.43375518 |
| 68 | EPHB1 | 0.43200708 |
| 69 | PDK1 | 0.42341463 |
| 70 | MAP2K1 | 0.39077355 |
| 71 | DDR2 | 0.38506971 |
| 72 | * PRKACA | 0.37628626 |
| 73 | MAP2K4 | 0.37482886 |
| 74 | * PRKACG | 0.34675942 |
| 75 | CAMK2G | 0.34658856 |
| 76 | DYRK1B | 0.32859363 |
| 77 | RET | 0.32662048 |
| 78 | PTK6 | 0.31640356 |
| 79 | ERBB3 | 0.30648525 |
| 80 | KSR2 | 0.30154353 |
| 81 | ITK | 0.28600371 |
| 82 | PRKCH | 0.28486586 |
| 83 | RPS6KA1 | 0.27805809 |
| 84 | NLK | 0.27278545 |
| 85 | AKT2 | 0.27038483 |
| 86 | ICK | 0.26941036 |
| 87 | PRKD3 | 0.25167764 |
| 88 | JAK1 | 0.24579935 |
| 89 | MAPK10 | 0.23980530 |
| 90 | LATS1 | 0.23321203 |
| 91 | RAF1 | 0.22435689 |
| 92 | AKT3 | 0.21781960 |
| 93 | SGK2 | 0.21389598 |
| 94 | PRKG2 | 0.20608825 |
| 95 | UHMK1 | 0.20203220 |
| 96 | LRRK2 | 0.20038750 |
| 97 | MAPK7 | 0.19185120 |
| 98 | PRKCQ | 0.18714335 |
| 99 | SGK3 | 0.18042176 |
| 100 | FER | 0.17618109 |
| 101 | * CAMK1 | 0.17053802 |
| 102 | FGFR4 | 0.16281873 |
| 103 | MAP3K10 | 0.15868136 |
| 104 | PDGFRB | 0.15617305 |
| 105 | LATS2 | 0.15504984 |
| 106 | PRKG1 | 0.14721024 |
| 107 | EPHB2 | 0.14518336 |
| 108 | RPS6KB2 | 0.14511534 |
| 109 | ADRBK1 | 0.14155398 |
| 110 | STK11 | 0.14140011 |
| 111 | SIK1 | 0.13775810 |
| 112 | MTOR | 0.13329913 |
| 113 | SGK1 | 0.12912718 |
| 114 | JAK2 | 0.12727274 |
| 115 | MAP2K6 | 0.12413192 |
| 116 | ZAP70 | 0.12061121 |
| 117 | RPS6KA3 | 0.11967361 |
| 118 | MAPK11 | 0.10881645 |
| 119 | FGFR3 | 0.10530823 |
| 120 | FGFR1 | 0.09541619 |
| 121 | MARK3 | 0.09408514 |
| 122 | EPHA3 | 0.09330288 |
| 123 | CDK5 | 0.08892503 |
| 124 | CCNB1 | 0.08597486 |
| 125 | TGFBR1 | 0.07774203 |
| 126 | MAP3K1 | 0.07715694 |
| 127 | PAK6 | 0.07134468 |
| 128 | LIMK1 | 0.06878420 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 6.30181050 |
| 2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 4.39063431 |
| 3 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 4.08541420 |
| 4 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.51791463 |
| 5 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.35883367 |
| 6 | * Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.31554655 |
| 7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.28895359 |
| 8 | Parkinsons disease_Homo sapiens_hsa05012 | 3.28395526 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.25690433 |
| 10 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.18847438 |
| 11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.60498381 |
| 12 | Carbon metabolism_Homo sapiens_hsa01200 | 2.54583074 |
| 13 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.46867135 |
| 14 | Alzheimers disease_Homo sapiens_hsa05010 | 2.40304002 |
| 15 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.34561465 |
| 16 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.20323688 |
| 17 | Huntingtons disease_Homo sapiens_hsa05016 | 2.06263700 |
| 18 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.88376593 |
| 19 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.63023991 |
| 20 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.61176578 |
| 21 | Viral myocarditis_Homo sapiens_hsa05416 | 1.59676711 |
| 22 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.58031160 |
| 23 | * Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.50321994 |
| 24 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.38092057 |
| 25 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.17531617 |
| 26 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.09877462 |
| 27 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.05191046 |
| 28 | Insulin resistance_Homo sapiens_hsa04931 | 1.01599237 |
| 29 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.92514447 |
| 30 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.92362699 |
| 31 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.90944919 |
| 32 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.85174270 |
| 33 | * cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.85119716 |
| 34 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.84233352 |
| 35 | Lysine degradation_Homo sapiens_hsa00310 | 0.82423052 |
| 36 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.79643814 |
| 37 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.79174776 |
| 38 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.76775680 |
| 39 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.72737228 |
| 40 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.68237730 |
| 41 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.64644049 |
| 42 | Focal adhesion_Homo sapiens_hsa04510 | 0.63924765 |
| 43 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.63782654 |
| 44 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.60945095 |
| 45 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.59019230 |
| 46 | Peroxisome_Homo sapiens_hsa04146 | 0.58707454 |
| 47 | * Calcium signaling pathway_Homo sapiens_hsa04020 | 0.58321654 |
| 48 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.57608182 |
| 49 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.53342479 |
| 50 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.51246317 |
| 51 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.47619973 |
| 52 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.47405083 |
| 53 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.46355921 |
| 54 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.45358414 |
| 55 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.45057674 |
| 56 | Salivary secretion_Homo sapiens_hsa04970 | 0.44952513 |
| 57 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.43905739 |
| 58 | Renin secretion_Homo sapiens_hsa04924 | 0.43874369 |
| 59 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.43553631 |
| 60 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.42582438 |
| 61 | Galactose metabolism_Homo sapiens_hsa00052 | 0.41671493 |
| 62 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.36925555 |
| 63 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.35407715 |
| 64 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.34922775 |
| 65 | * cAMP signaling pathway_Homo sapiens_hsa04024 | 0.33969122 |
| 66 | Tight junction_Homo sapiens_hsa04530 | 0.33908385 |
| 67 | Long-term potentiation_Homo sapiens_hsa04720 | 0.33622033 |
| 68 | Adherens junction_Homo sapiens_hsa04520 | 0.32043010 |
| 69 | * Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.31481774 |
| 70 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.31172458 |
| 71 | Melanogenesis_Homo sapiens_hsa04916 | 0.30452422 |
| 72 | GABAergic synapse_Homo sapiens_hsa04727 | 0.30057363 |
| 73 | Endometrial cancer_Homo sapiens_hsa05213 | 0.29996210 |
| 74 | Insulin secretion_Homo sapiens_hsa04911 | 0.29771865 |
| 75 | Morphine addiction_Homo sapiens_hsa05032 | 0.27440662 |
| 76 | Mineral absorption_Homo sapiens_hsa04978 | 0.27368084 |
| 77 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.26342696 |
| 78 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.26152630 |
| 79 | Metabolic pathways_Homo sapiens_hsa01100 | 0.25173132 |
| 80 | Amoebiasis_Homo sapiens_hsa05146 | 0.24931980 |
| 81 | Circadian entrainment_Homo sapiens_hsa04713 | 0.24913945 |
| 82 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.23538236 |
| 83 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.22448864 |
| 84 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.20551643 |
| 85 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.19114928 |
| 86 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.18319772 |
| 87 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.18070937 |
| 88 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.17674040 |
| 89 | Circadian rhythm_Homo sapiens_hsa04710 | 0.16626582 |
| 90 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.16082448 |
| 91 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.15714636 |
| 92 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.15353312 |
| 93 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.15036306 |
| 94 | Platelet activation_Homo sapiens_hsa04611 | 0.14605471 |
| 95 | Prion diseases_Homo sapiens_hsa05020 | 0.14278946 |
| 96 | Olfactory transduction_Homo sapiens_hsa04740 | 0.14118509 |
| 97 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.14036051 |
| 98 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.12899246 |
| 99 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.11082480 |
| 100 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.10746245 |
| 101 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.09308835 |
| 102 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.09114061 |
| 103 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.08995160 |
| 104 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.08942547 |
| 105 | Gap junction_Homo sapiens_hsa04540 | 0.08341878 |
| 106 | Taste transduction_Homo sapiens_hsa04742 | 0.06760850 |
| 107 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.05934426 |
| 108 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.05328027 |
| 109 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.05030849 |
| 110 | Bile secretion_Homo sapiens_hsa04976 | 0.04533141 |
| 111 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.04254312 |
| 112 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.03937578 |
| 113 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.03118296 |
| 114 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.01431885 |
| 115 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.00150101 |
| 116 | Rap1 signaling pathway_Homo sapiens_hsa04015 | -0.0348321 |
| 117 | FoxO signaling pathway_Homo sapiens_hsa04068 | -0.0184625 |
| 118 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | -0.0037637 |

